I wonder if it means "up to and including Phase II clinical experience"... and if the company intends to inform the market of the extent and outcome of such evaluations?
Speaking of "experience"... it would be nice to experience that thing called newsflow, hey?
I wonder if it means "up to and including Phase II clinical...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PTX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.1¢ |
Change
0.001(2.50%) |
Mkt cap ! $33.01M | |||
| Open | High | Low | Value | Volume |
| 4.1¢ | 4.1¢ | 4.1¢ | $3.306K | 81.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 1355555 | 4.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.1¢ | 24403 | 1 |
View Market Depth
| Last trade - 15.45pm 05/11/2024 (20 minute delay) ? |
| PTX (ASX) Chart |